1.700
+0,00%
2026-10-19
Fundamental Analysis
19 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -1638.7% | -622.7% | 0 / 3 | -24.7% | -17.31 pp | -19.51 pp | -6.2% | 0.41 | — | 10,6 | −24,7% | −2,0 | −1.638,7% | — | -14.34 | — |
| Pts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 1.700 (close price on 2026-10-19)EPS (TTM): −394,8
Financial charts
1.Revenue & growth
VND bn10,6Q2/26
1.Revenue & growth
VND bn10,6Q2/26
2.Profit & growth
VND bn-1,92Q2/26
3.Profit mix (Penman)
VND bn-5,00Q2/26
4.Margins & cost structure
%20.0%Q2/26
5.Returns & cash cycle
% · days-2.6%Q2/26
6.Earnings quality & cash
VND bn0,57Q2/26
7.Asset structure
VND bn185Q2/26
8.Funding & debt health
VND bn · times185Q2/26
9.Revenue backlog
VND bn4,60Q2/26
10.Valuation
times · %-4,4×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-150Q2/26
Adjusted EPS growth, latest quarter
-1593%
Average adjusted EPS growth, 3 quarters
-898%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26